Cargando…

Abnormal laboratory values during the acute and recovery phases in schizophrenic patients: a retrospective study

During treatment of acute-phase schizophrenia, attention needs to be given to physical as well as psychological symptoms. It is often difficult, however, to obtain information on physical symptoms from patients with psychomotor excitation, and only laboratory examinations can provide objective data....

Descripción completa

Detalles Bibliográficos
Autor principal: Nagamine, Takahiko
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2898166/
https://www.ncbi.nlm.nih.gov/pubmed/20634880
_version_ 1782183482304233472
author Nagamine, Takahiko
author_facet Nagamine, Takahiko
author_sort Nagamine, Takahiko
collection PubMed
description During treatment of acute-phase schizophrenia, attention needs to be given to physical as well as psychological symptoms. It is often difficult, however, to obtain information on physical symptoms from patients with psychomotor excitation, and only laboratory examinations can provide objective data. The results of laboratory parameters measured in 68 patients with schizophrenia during psychomotor excitation and approximately 1 month later during the medicated recovery phase have been analyzed retrospectively. Abnormal laboratory values during psychomotor excitation were frequent. The most frequent (≥35% of patients) were increased white blood cell count, low serum potassium levels, high levels of fasting blood sugar, lactate dehydrogenase and uric acid. There were fewer abnormal values during the medicated recovery phase. The most frequent (≥25% of patients) were high serum levels of triglycerides, amylase, creatinine kinase, and low-density lipoprotein cholesterol. Abnormal triglyceride levels were found significantly more frequently in patients receiving olanzapine than those receiving risperidone. Abnormal values during the acute phase may be the result of excitation such as increased sympathetic tone and dehydration. Abnormal values during the recovery phase appeared to be related to the adverse metabolic effects of antipsychotic drugs. The frequency of these abnormal values was particularly high in patients receiving olanzapine alone or in combination with other medications.
format Text
id pubmed-2898166
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-28981662010-07-15 Abnormal laboratory values during the acute and recovery phases in schizophrenic patients: a retrospective study Nagamine, Takahiko Neuropsychiatr Dis Treat Original Research During treatment of acute-phase schizophrenia, attention needs to be given to physical as well as psychological symptoms. It is often difficult, however, to obtain information on physical symptoms from patients with psychomotor excitation, and only laboratory examinations can provide objective data. The results of laboratory parameters measured in 68 patients with schizophrenia during psychomotor excitation and approximately 1 month later during the medicated recovery phase have been analyzed retrospectively. Abnormal laboratory values during psychomotor excitation were frequent. The most frequent (≥35% of patients) were increased white blood cell count, low serum potassium levels, high levels of fasting blood sugar, lactate dehydrogenase and uric acid. There were fewer abnormal values during the medicated recovery phase. The most frequent (≥25% of patients) were high serum levels of triglycerides, amylase, creatinine kinase, and low-density lipoprotein cholesterol. Abnormal triglyceride levels were found significantly more frequently in patients receiving olanzapine than those receiving risperidone. Abnormal values during the acute phase may be the result of excitation such as increased sympathetic tone and dehydration. Abnormal values during the recovery phase appeared to be related to the adverse metabolic effects of antipsychotic drugs. The frequency of these abnormal values was particularly high in patients receiving olanzapine alone or in combination with other medications. Dove Medical Press 2010 2010-06-24 /pmc/articles/PMC2898166/ /pubmed/20634880 Text en © 2010 Nagamine, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Original Research
Nagamine, Takahiko
Abnormal laboratory values during the acute and recovery phases in schizophrenic patients: a retrospective study
title Abnormal laboratory values during the acute and recovery phases in schizophrenic patients: a retrospective study
title_full Abnormal laboratory values during the acute and recovery phases in schizophrenic patients: a retrospective study
title_fullStr Abnormal laboratory values during the acute and recovery phases in schizophrenic patients: a retrospective study
title_full_unstemmed Abnormal laboratory values during the acute and recovery phases in schizophrenic patients: a retrospective study
title_short Abnormal laboratory values during the acute and recovery phases in schizophrenic patients: a retrospective study
title_sort abnormal laboratory values during the acute and recovery phases in schizophrenic patients: a retrospective study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2898166/
https://www.ncbi.nlm.nih.gov/pubmed/20634880
work_keys_str_mv AT nagaminetakahiko abnormallaboratoryvaluesduringtheacuteandrecoveryphasesinschizophrenicpatientsaretrospectivestudy